header advert
Results 1 - 2 of 2
Results per page:
Orthopaedic Proceedings
Vol. 98-B, Issue SUPP_23 | Pages 11 - 11
1 Dec 2016
Sadique H Evans S Parry M Stevenson J Reeves N Mimmack S Jumaa P Jeys L
Full Access

Aim

Compare clinical outcomes following staged revision arthroplasty for periprosthetic joint infection (PJI) secondary to either multidrug resistant (MDR) bacteria or non-MDR (NMDR) bacteria.

Method

Retrospective analysis of a prospectively collected bone infection database. Adult patients diagnosed and treated for hip or knee PJI, between January 2011 and December 2014, with minimum one-year follow-up, were included in the study. Patients were divided into two groups: MDR group (defined as resistance to 3 or more classes) and N-MDR group (defined as acquired resistance to two classes of antibiotic or less).

The Charlson Comorbidity Index was used to stratify patients into low, medium and high risk.

The diagnosis of PJI, and any recurrence following treatment, was made in accordance with the Musculoskeletal Infection Society criteria. Failure was defined as recurrence of infection necessitating implant removal, excision arthroplasty, arthrodesis or amputation.


Orthopaedic Proceedings
Vol. 98-B, Issue SUPP_23 | Pages 61 - 61
1 Dec 2016
Sidhu M Jumaa P Parry M Jeys L Stevenson J
Full Access

Aim

Periprosthetic joint infections (PJI) are rare and require complex multi-disciplinary management. Successful single and two-stage revision procedures have been described. We describe the clinical features of this rare diagnosis from a single institution.

Method

Patients were identified retrospectively from a prospectively collected institutional infection database. Clinical notes were evaluated for demographic, comorbid and clinical outcomes. The diagnosis of PJI, and any recurrence following treatment, was made in accordance with the Musculoskeletal Infection Society criteria. Failure was defined as recurrence of infection necessitating implant removal, excision arthroplasty or amputation.